Tempus Ai Cl A (TEM)

$49.36 -2.28 (-4.42%)
Market Cap 9.32B
Revenue (ttm) 1.27B
Net Income (ttm) -245.03M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -19.27%
Debt to Equity Ratio 0.00
Volume 3,517,300
Avg Vol 5,526,672
Day's Range N/A - N/A
Shares Out 180.44M
Stochastic %K 37%
Beta 3.58
Analysts Sell
Price Target $61.80

Company Profile

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also...

Industry: Health Information Services
Sector: Healthcare
Phone: 800 976 5448
Fax: 800 893 0276
Address:
600 West Chicago Avenue, Suite 510, Chicago, United States
turk1905
turk1905 Aug. 19 at 3:11 PM
$TEM $69 per share today
0 · Reply
DelScorcho
DelScorcho Aug. 19 at 3:07 PM
$TEM these are the kind of clowns you block. How lots of people follow his BS is a mystery. “Wisdom” 😂🤣
0 · Reply
howardlindzon
howardlindzon Aug. 19 at 3:01 PM
$TEM
1 · Reply
wisdom_trade
wisdom_trade Aug. 19 at 2:59 PM
$TEM pure Garbage stock. No position
1 · Reply
wisdom_trade
wisdom_trade Aug. 19 at 2:58 PM
$TEM is sellbrated
0 · Reply
thewheel25
thewheel25 Aug. 19 at 2:58 PM
$TEM covered calls today
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Aug. 19 at 2:57 PM
Top Trending Stocks Today (August 19, 2026): $TEM The Profitable Pivot - Resistance: $60.00. $WULF The “Growing Pains” Pullback - Resistance: $16.50. $AVGO Resistance: $380.00. $MRK The “Keytruda” Booster - Resistance: $155.00. $IOVA Resistance: $8.00. https://truthsandnews.com/markets/top-trending-stocks-today-aug-19-2026-mrna-143-tgt
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:57 PM
$TEM Healthcare is the Anti - AI trade... well with Tempus you get the best of both worlds.
0 · Reply
thebullaltra
thebullaltra Aug. 19 at 2:56 PM
$TEM will it hit 75?
0 · Reply
nly
nly Aug. 19 at 2:53 PM
$TEM patience pays off
0 · Reply
Latest News on TEM
Tempus AI added to CellCarta’s CDx commercialization lab network

2026-08-06T13:36:58.000Z - 13 days ago

Tempus AI added to CellCarta’s CDx commercialization lab network

CellCarta Adds Tempus to CDx Commercialization Lab Network

Aug 6, 2026, 9:15 AM EDT - 13 days ago

CellCarta Adds Tempus to CDx Commercialization Lab Network

Personalis says not providing guidance or conducting earnings call

2026-08-04T20:11:59.000Z - 14 days ago

Personalis says not providing guidance or conducting earnings call

PSNL

Tempus AI announces study results of PRISM2

2026-08-04T12:36:32.000Z - 15 days ago

Tempus AI announces study results of PRISM2

MSFT

Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

Aug 4, 2026, 8:30 AM EDT - 15 days ago

Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications

Tempus AI price target lowered to $56 from $58 at Piper Sandler

2026-08-04T10:56:32.000Z - 15 days ago

Tempus AI price target lowered to $56 from $58 at Piper Sandler

Tempus AI price target lowered to $70 from $80 at BTIG

2026-08-03T17:55:13.000Z - 15 days ago

Tempus AI price target lowered to $70 from $80 at BTIG

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

2026-08-03T17:15:23.000Z - 15 days ago

Tempus AI price target lowered to $56 from $64 at H.C. Wainwright

Tempus AI price target lowered to $52 from $64 at BofA

2026-08-03T11:32:04.000Z - 16 days ago

Tempus AI price target lowered to $52 from $64 at BofA

Tempus AI price target lowered to $50 from $60 at Stifel

2026-08-03T10:50:59.000Z - 16 days ago

Tempus AI price target lowered to $50 from $60 at Stifel

Tempus AI price target lowered to $59 from $67 at Baird

2026-07-31T11:25:29.000Z - 19 days ago

Tempus AI price target lowered to $59 from $67 at Baird

Tempus AI Earnings Call Transcript: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Tempus AI Earnings Call Transcript: Q2 2026

Tempus AI Earnings release: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Tempus AI Earnings release: Q2 2026

Tempus AI Quarterly report: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Tempus AI Quarterly report: Q2 2026

Tempus AI Slides: Q2 2026

Jul 30, 2026, 4:30 PM EDT - 19 days ago

Tempus AI Slides: Q2 2026

Tempus AI raises FY26 revenue view to $1.595B-$1.605B, consensus $1.59B

2026-07-30T20:12:48.000Z - 19 days ago

Tempus AI raises FY26 revenue view to $1.595B-$1.605B, consensus $1.59B

Tempus AI reports Q2 adjusted EPS (4c), consensus (15c)

2026-07-30T20:05:46.000Z - 19 days ago

Tempus AI reports Q2 adjusted EPS (4c), consensus (15c)

Tempus Reports Second Quarter 2026 Results

Jul 30, 2026, 4:01 PM EDT - 19 days ago

Tempus Reports Second Quarter 2026 Results

Tempus AI announces national launch of OneOme pharmacogenomics testing

2026-07-22T12:36:30.000Z - 4 weeks ago

Tempus AI announces national launch of OneOme pharmacogenomics testing

Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

Jul 22, 2026, 8:30 AM EDT - 4 weeks ago

Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine

Personalis price target raised to $16.25 from $11 at BTIG

2026-07-21T10:41:24.000Z - 4 weeks ago

Personalis price target raised to $16.25 from $11 at BTIG

PSNL

Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a “Market Misread”

2026-07-20T20:18:32.000Z - 4 weeks ago

Tempus AI (TEM) Drops on $1.7B Personalis Deal; Needham Analyst Calls the Slide a “Market Misread”

PSNL

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

2026-07-20T18:45:13.000Z - 4 weeks ago

Morgan Stanley sees strategic logic in Personalis deal despite financial hurdles

PSNL

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

2026-07-20T18:20:22.000Z - 4 weeks ago

AI Daily: Tempus AI to acquire Personalis at enterprise value of $1.5B

AMTM GOOG GOOGL NVDA PSNL QMLS XMTR

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

2026-07-20T16:00:42.000Z - 4 weeks ago

Midday Fly By: Domino’s reports mixed Q2, Tempus AI to acquire Personalis

AAPL ACHR AER AMC BA BABA BAM

Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink

Jul 20, 2026, 10:44 AM EDT - 4 weeks ago

Tempus AI Buys Personalis for $1.5 Billion, and Both Stocks Sink

PSNL

Personalis downgraded to Hold from Buy at Lake Street

2026-07-20T14:10:32.000Z - 4 weeks ago

Personalis downgraded to Hold from Buy at Lake Street

PSNL

Tempus AI Press release: M&A announcement

Jul 20, 2026, 9:00 AM EDT - 4 weeks ago

Tempus AI Press release: M&A announcement

Tempus AI Slides: M&A announcement

Jul 20, 2026, 9:00 AM EDT - 4 weeks ago

Tempus AI Slides: M&A announcement

Tempus to acquire Personalis for $1.5 billion

Jul 20, 2026, 8:44 AM EDT - 4 weeks ago

Tempus to acquire Personalis for $1.5 billion

PSNL

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

Jul 20, 2026, 8:30 AM EDT - 4 weeks ago

Tempus to Acquire Personalis, More Tightly Integrating Molecular Residual Disease (MRD) into Its AI-Enabled Precision Oncology Platform

PSNL

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

Jul 16, 2026, 8:30 AM EDT - 4 weeks ago

Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service

Tempus to Report Second Quarter 2026 Financial Results on July 30

Jul 9, 2026, 9:00 AM EDT - 5 weeks ago

Tempus to Report Second Quarter 2026 Financial Results on July 30

Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Jun 25, 2026, 8:30 AM EDT - 7 weeks ago

Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers

Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms

Jun 16, 2026, 5:07 PM EDT - 2 months ago

Tempus AI (TEM) Price Forecast: Consolidation Bottom Breakout Looms

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Jun 11, 2026, 8:30 AM EDT - 2 months ago

Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm

Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Jun 9, 2026, 6:00 AM EDT - 2 months ago

Genetics in Medicine Open Study Demonstrates How Ambry Genetics' ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing

Tempus AI Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Jun 8, 2026, 2:00 PM EDT - 2 months ago

Tempus AI Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026

Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Jun 5, 2026, 4:01 PM EDT - 2 months ago

Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members

Jun 3, 2026, 8:30 AM EDT - 2 months ago

Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

Jun 1, 2026, 8:30 AM EDT - 2 months ago

Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH

Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development

May 31, 2026, 8:30 AM EDT - 2 months ago

Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

May 30, 2026, 8:30 AM EDT - 2 months ago

Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community

Tempus Introduces ‘Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

May 30, 2026, 8:00 AM EDT - 2 months ago

Tempus Introduces ‘Preview': Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

May 29, 2026, 9:15 AM EDT - 2 months ago

Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology

Tempus AI Transcript: Investor Day 2026

May 29, 2026, 9:00 AM EDT - 2 months ago

Tempus AI Transcript: Investor Day 2026

Tempus AI Slides: FY 2026

May 29, 2026, 9:00 AM EDT - 2 months ago

Tempus AI Slides: FY 2026

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

May 29, 2026, 8:15 AM EDT - 2 months ago

Tempus Receives FDA Approval for Tumor Only xT CDx, Enabling Migration of its Entire DNA Solid Tumor Portfolio

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

May 28, 2026, 8:30 AM EDT - 2 months ago

Tempus Expands Next Platform to Deliver Real-Time Clinical Intelligence and Close Critical Care Gaps Across Oncology

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

May 27, 2026, 8:33 AM EDT - 3 months ago

Tempus Upgrades Its Smart Physician Platform, Hub, with Next-Generation Agentic AI Architecture to Streamline Clinical Workflows

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

May 26, 2026, 8:30 AM EDT - 3 months ago

Tempus Announces 37 Abstracts Accepted for Presentation at the 2026 American Society of Clinical Oncology Annual Meeting

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

May 21, 2026, 8:30 AM EDT - 3 months ago

Tempus Launches ArteraAI Prostate Test for Metastatic Patients, Marking the First Prostate Digital Pathology Algorithm in the Tempus Ecosystem Available for Clinical Use

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

May 14, 2026, 8:30 AM EDT - 3 months ago

Tempus Expands Strategic Collaboration with Bristol Myers Squibb to Enhance the Probability of Success Across Clinical Development Programs In Oncology and Neuroscience

BMY

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

May 11, 2026, 6:00 AM EDT - 3 months ago

Ambry Genetics' CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

May 8, 2026, 12:59 AM EDT - 3 months ago

Tempus Announces Pricing of Upsized Offering of $400.0 Million of Convertible Senior Notes

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

May 7, 2026, 7:11 AM EDT - 3 months ago

Tempus AI, Inc. Announces Proposed Convertible Senior Notes Offering to Optimize Capital Structure and Reduce Interest Expense

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

May 6, 2026, 8:00 AM EDT - 3 months ago

Lucent Diagnostics Announces Collaboration with Tempus to Integrate Blood-Based Alzheimer's Biomarker Testing into Clinical Workflows

QTRX

Tempus AI Earnings Call Transcript: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Earnings Call Transcript: Q1 2026

Tempus AI Earnings release: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Earnings release: Q1 2026

Tempus AI Slides: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Slides: Q1 2026

Tempus AI Quarterly report: Q1 2026

May 5, 2026, 4:30 PM EDT - 3 months ago

Tempus AI Quarterly report: Q1 2026

Tempus Reports First Quarter 2026 Results

May 5, 2026, 4:01 PM EDT - 3 months ago

Tempus Reports First Quarter 2026 Results

Tempus to Host Inaugural Investor Day on May 29, 2026

Apr 29, 2026, 8:30 AM EDT - 4 months ago

Tempus to Host Inaugural Investor Day on May 29, 2026

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Apr 28, 2026, 8:30 AM EDT - 4 months ago

Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Apr 23, 2026, 8:30 AM EDT - 4 months ago

Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine

Tempus to Report First Quarter 2026 Financial Results on May 5

Apr 21, 2026, 8:30 AM EDT - 4 months ago

Tempus to Report First Quarter 2026 Financial Results on May 5

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Apr 15, 2026, 8:30 AM EDT - 4 months ago

Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Apr 14, 2026, 11:45 AM EDT - 4 months ago

Tempus AI Transcript: 25th Annual Needham Virtual Healthcare Conference

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Apr 14, 2026, 8:30 AM EDT - 4 months ago

Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Apr 13, 2026, 8:30 AM EDT - 4 months ago

Tempus Launches Automated “Active Follow-Up” Service to Support Guideline-Concordant Care

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

Apr 9, 2026, 8:30 AM EDT - 4 months ago

Tempus Announces Strategic Collaboration with Gilead to Advance Oncology R&D Through RWE

GILD

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Apr 8, 2026, 4:01 PM EDT - 4 months ago

Tempus to Present at the 25th Annual Needham Virtual Healthcare Conference

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Tempus AI Proxy statement: Proxy filing

Tempus AI Proxy statement: Proxy filing

Apr 7, 2026, 8:00 AM EDT - 4 months ago

Tempus AI Proxy statement: Proxy filing

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Apr 1, 2026, 8:30 AM EDT - 5 months ago

Tempus and Medtronic Announce ALERT Trial Results Showing AI-Driven EHR Notifications Improve Treatment for Significant Valvular Heart Disease

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Mar 17, 2026, 8:30 AM EDT - 5 months ago

Tempus and Blood Cancer United® Announce Collaboration to Develop One Of the Largest Pediatric Acute Myeloid Leukemia Real-World Data Registries

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Mar 11, 2026, 8:30 AM EDT - 5 months ago

Tempus Announces Study Highlighting the Role of Advanced Genomic Profiling Features in Identifying Clinically Actionable Findings

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Mar 3, 2026, 12:15 PM EST - 6 months ago

Tempus AI Transcript: Morgan Stanley Technology, Media & Telecom Conference 2026

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Mar 3, 2026, 8:30 AM EST - 6 months ago

Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Feb 26, 2026, 8:30 AM EST - 6 months ago

Tempus to Participate in the Morgan Stanley Technology, Media & Telecom Conference

Tempus AI Earnings Call Transcript: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

Tempus AI Earnings Call Transcript: Q4 2025

Tempus AI Annual report: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

Tempus AI Annual report: Q4 2025

Tempus AI Earnings release: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

Tempus AI Earnings release: Q4 2025

Tempus AI Slides: Q4 2025

Feb 24, 2026, 4:30 PM EST - 6 months ago

Tempus AI Slides: Q4 2025

Tempus Reports Fourth Quarter and Full Year 2025 Results

Feb 24, 2026, 4:01 PM EST - 6 months ago

Tempus Reports Fourth Quarter and Full Year 2025 Results

Is TEM Stock A Buy At $60?

Feb 19, 2026, 11:01 AM EST - 6 months ago

Is TEM Stock A Buy At $60?

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

Feb 18, 2026, 8:30 AM EST - 6 months ago

Tempus Announces Novel Pan-Cancer HRD-RNA Algorithm

turk1905
turk1905 Aug. 19 at 3:11 PM
$TEM $69 per share today
0 · Reply
DelScorcho
DelScorcho Aug. 19 at 3:07 PM
$TEM these are the kind of clowns you block. How lots of people follow his BS is a mystery. “Wisdom” 😂🤣
0 · Reply
howardlindzon
howardlindzon Aug. 19 at 3:01 PM
$TEM
1 · Reply
wisdom_trade
wisdom_trade Aug. 19 at 2:59 PM
$TEM pure Garbage stock. No position
1 · Reply
wisdom_trade
wisdom_trade Aug. 19 at 2:58 PM
$TEM is sellbrated
0 · Reply
thewheel25
thewheel25 Aug. 19 at 2:58 PM
$TEM covered calls today
0 · Reply
TNNStockAnalysisNews
TNNStockAnalysisNews Aug. 19 at 2:57 PM
Top Trending Stocks Today (August 19, 2026): $TEM The Profitable Pivot - Resistance: $60.00. $WULF The “Growing Pains” Pullback - Resistance: $16.50. $AVGO Resistance: $380.00. $MRK The “Keytruda” Booster - Resistance: $155.00. $IOVA Resistance: $8.00. https://truthsandnews.com/markets/top-trending-stocks-today-aug-19-2026-mrna-143-tgt
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:57 PM
$TEM Healthcare is the Anti - AI trade... well with Tempus you get the best of both worlds.
0 · Reply
thebullaltra
thebullaltra Aug. 19 at 2:56 PM
$TEM will it hit 75?
0 · Reply
nly
nly Aug. 19 at 2:53 PM
$TEM patience pays off
0 · Reply
JFDI
JFDI Aug. 19 at 2:52 PM
$TEM 200d pocket pivot with close over 57
0 · Reply
thebullaltra
thebullaltra Aug. 19 at 2:50 PM
$TEM please 100
0 · Reply
CR7LOVE
CR7LOVE Aug. 19 at 2:48 PM
$TEM when 70? Hopefully soon.
0 · Reply
TICKERTUTOR
TICKERTUTOR Aug. 19 at 2:37 PM
$TEM 31% of the float is short.... Merck-Moderna positive Phase 3 mRNA cancer vaccine data lifts Tempus AI shares INTerpath-001 trial met primary RFS and key secondary DMFS endpoints in high-risk melanoma First positive Phase 3 readout for individualized neoantigen therapy (mRNA-4157 + Keytruda) Tempus partners with Moderna on program using AI, genomics, and sequencing for neoantigen ID CEO Eric Lefkofsky tweeted congratulations highlighting the collaboration Builds on Tempus' recent FDA CDx approvals and oncology data platform momentum
0 · Reply
thebullaltra
thebullaltra Aug. 19 at 2:37 PM
$TEM anyone buying calls ? $MRNA
0 · Reply
DelScorcho
DelScorcho Aug. 19 at 2:34 PM
$TEM I may end up being right after all! 😇🙏
0 · Reply
BeachTrader777
BeachTrader777 Aug. 19 at 2:34 PM
$TEM back to ATH on $MRNA news
0 · Reply
Snowdawg12
Snowdawg12 Aug. 19 at 2:34 PM
$TEM
0 · Reply
AcceleratorModel
AcceleratorModel Aug. 19 at 2:33 PM
$TEM getting some love from mRNA nice
0 · Reply
Snowdawg12
Snowdawg12 Aug. 19 at 2:32 PM
$TEM retest at 200MA
0 · Reply
MDHOOD
MDHOOD Aug. 19 at 2:31 PM
$TEM lets go finally-- 30% short with about 5 days to cover. We can do this. 😃🦾
0 · Reply
beestMod516
beestMod516 Aug. 19 at 2:19 PM
$TEM one of those days it can hit $70
0 · Reply